Korean Circulation Journal

  • 제42권11호
  • /
  • Pages.788-791
  • /
  • 2012
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

The First Case of Successful Transcatheter Aortic Valve Implantation Using CoreValve in Korea

  • Kim, In-Soo (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Ko, Young-Guk (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Shin, Sanghoon (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Shim, Ji-Young (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Lee, Sak (Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Chang, Byung-Chul (Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Shim, Jae-Kwang (Department of Anesthesiology and Pain Medicine, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Kwak, Young-Ran (Department of Anesthesiology and Pain Medicine, Severance Cardiovascular Hospital, Yonsei University Health System) ;
  • Hong, Myeong-Ki (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System)
  • 발행 : 2012.11.30
⟨ 이전 논문 다음 논문 ⟩

초록

Surgical replacement of the aortic valve is the standard therapy for severe aortic valve stenosis. However, it is generally associated with increased mortality and morbidities in older individuals. Transcatheter aortic valve implantation (TAVI) is a less invasive procedure and has shown similar clinical outcomes as surgical treatment in elderly patients at high risk for conventional surgery. In this report, we describe the first case of TAVI using a CoreValve in Korea. An 84-year-old man with symptomatic severe aortic valve stenosis was successfully treated by transfemoral TAVI. The patient was discharged without any significant complications and remained free of adverse clinical event for a follow-up duration of 6 months.

키워드

참고문헌

  1. Goncalves A, Marcos-Alberca P, Almeria C, et al. Quality of life improvement at midterm follow-up after transcatheter aortic valve implantation. Int J Cardiol 2011. [Epub ahead of print]
  2. Walther T, Kempfert J, Rastan A, et al. Transapical aortic valve implantation at 3 years. J Thorac Cardiovasc Surg 2012;143:326-31. https://doi.org/10.1016/j.jtcvs.2010.10.063
  3. Ben-Dor I, Gaglia MA Jr, Barbash IM, et al. Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation. Cardiovasc Revasc Med 2011;12:345-9. https://doi.org/10.1016/j.carrev.2011.04.005
  4. Ong SH, Beucher H, Mueller R, Gerckens U, Boekstegers P. Percutaneous double-valve interventions for aortic stenosis and pure mitral regurgitation. Am J Cardiol 2011;108:893-5. https://doi.org/10.1016/j.amjcard.2011.05.017
  5. Webb J, Cribier A. Percutaneous transarterial aortic valve implantation: what do we know? Eur Heart J 2011;32:140-7. https://doi.org/10.1093/eurheartj/ehq453
  6. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607. https://doi.org/10.1056/NEJMoa1008232
  7. Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B). Circulation 2012;125:1102-9. https://doi.org/10.1161/CIRCULATIONAHA.111.054072
  8. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic- valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98. https://doi.org/10.1056/NEJMoa1103510
  9. Rodes-Cabau J. Progress in transcatheter aortic valve implantation. Rev Esp Cardiol 2010;63:439-50. https://doi.org/10.1016/S0300-8932(10)70065-8
  10. Toutouzas K, Michelongona A, Synetos A, Latsios G, Tsioufis C, Stefanadis C. Atrioventricular block 9 days after transcatheter aortic valve implantation. Int J Cardiol 2011;151:112-4. https://doi.org/10.1016/j.ijcard.2011.06.023
  11. Chu MW, Falk V, Mohr FW, Walther T. Percutaneous endoscopic transapical aortic valve implantation: three experimental transcatheter models. Interact Cardiovasc Thorac Surg 2011;13:251-6. https://doi.org/10.1510/icvts.2011.274852
  12. Sarkar K, Ussia GP, Tamburino C. Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the Core Valve revalving system-technical tips and role of the Accutrak system. Catheter Cardiovasc Interv 2011;78:485-90.
  13. Azadani AN, Jaussaud N, Ge L, Chitsaz S, Chuter TA, Tseng EE. Valve-invalve hemodynamics of 20-mm transcatheter aortic valves in small bioprostheses. Ann Thorac Surg 2011;92:548-55. https://doi.org/10.1016/j.athoracsur.2011.04.009